Systematic Review of Treatments for Autoimmune Inner Ear Disease

被引:13
作者
Brant, Jason A. [1 ]
Eliades, Steven J. [1 ]
Ruckenstein, Michael J. [1 ]
机构
[1] Hosp Univ Penn, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA
关键词
Autoimmune inner ear disease; Hearing loss; Systematic review; SENSORINEURAL HEARING-LOSS; MEDIATED COCHLEOVESTIBULAR DISORDERS; NECROSIS-FACTOR-ALPHA; COCHLEAR IMPLANTATION; ETANERCEPT THERAPY; OPEN-LABEL; METHOTREXATE; TRIAL; PLASMAPHERESIS; DEAFNESS;
D O I
10.1097/MAO.0000000000000875
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To systematically evaluate the evidence for treatment of autoimmune inner ear disease (AIED). Data Sources: Medline/EMBASE, Cochrane Review. Study Selection: Studies reviewed were English language original articles reporting outcome data for subjects with AIED undergoing any treatment other than oral steroids alone with particular emphasis on prospectively collected data. Data Extraction: The full text of articles meeting selection criteria was reviewed for subject inclusion criteria, number of subjects, treatment type and duration, audiologic and vestibular evaluations, blinding, randomization, and follow-up. Data Synthesis: Twelve studies representing 272 subjects met selection criteria and presented prospective data, three of which were randomized and placebo controlled. Low numbers and heterogeneity between studies precluded meta analysis. Conclusions: Clear evidence of an effective treatment for AIED from high-quality prospective trials remains lacking.
引用
收藏
页码:1585 / 1592
页数:8
相关论文
共 55 条
[1]   Cochlear Implantation Outcomes in Patients With Autoimmune and Immune-Mediated Inner Ear Disease [J].
Aftab, Saba ;
Semaan, Maroun T. ;
Murray, Gail S. ;
Megerian, Cliff A. .
OTOLOGY & NEUROTOLOGY, 2010, 31 (08) :1337-1342
[2]   PLASMA-EXCHANGE IN THE TREATMENT OF IMMUNE COMPLEX-ASSOCIATED SENSORINEURAL DEAFNESS [J].
BROOKES, GB ;
NEWLAND, AC .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1986, 100 (01) :25-33
[3]  
BROOKES GB, 1985, J ROY SOC MED, V78, P47
[4]  
Campbell K C, 2000, J Am Acad Audiol, V11, P361
[5]   Etanercept treatment for autoimmune inner ear disease: Results of a pilot placebo-controlled study [J].
Cohen, S ;
Shoup, T ;
Weisman, MH ;
Harris, J .
OTOLOGY & NEUROTOLOGY, 2005, 26 (05) :903-907
[6]   A Pilot Study of Rituximab in Immune-Mediated Inner Ear Disease [J].
Cohen, Stanley ;
Roland, Peter ;
Shoup, Angela ;
Lowenstein, Mitchell ;
Silverstein, Herbert ;
Kavanaugh, Arthur ;
Harris, Jeffrey .
AUDIOLOGY AND NEURO-OTOLOGY, 2011, 16 (04) :214-221
[7]  
Derebery MJ, 2014, OTOL NEUROTOL, V35, P1515, DOI 10.1097/MAO.0000000000000566
[8]   Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease:: a physiopathologic approach [J].
Garcia-Berrocal, Jose Ramon ;
Ibanez, Andres ;
Rodriguez, Antonio ;
Gonzalez-Garcia, Jose Angel ;
Verdaguer, Jose Maria ;
Trinidad, Almudena ;
Ramirez-Camacho, Rafael .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (11) :977-982
[9]   Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate - A randomized controlled trial [J].
Harris, JP ;
Weisman, MH ;
Derebery, JM ;
Espeland, MA ;
Gantz, BJ ;
Gulya, AJ ;
Hammerschlag, PE ;
Hannley, M ;
Hughes, GB ;
Moscicki, R ;
Nelson, RA ;
Niparko, JK ;
Rauch, SD ;
Telian, SA ;
Brookhouser, PE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (14) :1875-1883
[10]   Autoimmune Inner Ear Disease in Children [J].
Huang, Natalie C. ;
Sataloff, Robert T. .
OTOLOGY & NEUROTOLOGY, 2011, 32 (02) :213-216